US Pharma MarketingVera eyes full approval for Trutakna in IgAN following positive readout
Vera Therapeutics Topic Hubs AI drug discovery: News, analysis and interviews Antibody-drug conjugates: The next wave of targeted cancer drugs Biopharma M&A and dealmaking: Who’s buying and why Biopharma people moves: CEO changes, executive hires, board positions Biotech IPOs: Tracking the market for new public offerings Biotech venture funding: Who’s raising and where the money is going Cell and gene therapy manufacturing: Scaling the next frontier China biotech: Licensing deals and the Biosecure Act CRISPR and gene editing: The push for in vivo therapies Drug pricing and the IRA: Tracking the government's negotiation power FDA policy and drug approvals: What’s…
Vera Therapeutics said two-year data show its recently approved drug Trutakna stabilized kidney function in patients with a chronic autoimmune disease, setting the drug up for another FDA submission.
Trutakna won an
Source: Endpoints News